Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Major new launches for 2014

March 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10

 AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …

Feature
Novartis image

Novartis extends trial transparency

February 27, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency

Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.

News
novartis image

Novartis to axe Horsham site

February 27, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure

Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

News
Novartis image

Skin cancer pill shows ‘significant’ response

February 20, 2014
Research and Development, Sales and Marketing LDE225, Novartis, bolt, skin cancer, smo

Novartis is celebrating after its investigational pill targeting the most common form of skin cancer met its primary endpoint in …

News

Police raid Novartis Tokyo office

February 20, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, tokyo

Authorities in Japan have raided the premises of Novartis’ Tokyo operation as part of an ongoing investigation into the promotion …

News

Novartis pays out for US biotech

February 17, 2014
Research and Development, Sales and Marketing Cancer, Novartis, Vaccine, costim pharmaceuticals

Novartis is looking to shore up its cancer immunotherapy pipeline with the purchase of oncology specialist CoStim Pharmaceuticals. The Cambridge, …

News

Sales rise for Novartis

January 30, 2014
Sales and Marketing Gleevec, Glivec, Novartis, gilenya, q4, sales

Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …

News

Novartis may axe 1,000 jobs in Diovan wake

January 23, 2014
Manufacturing and Production, Sales and Marketing Coartem, Diovan, Novartis, cuts

Novartis will shut down a plant in New York State that made heart drug Diovan and malaria treatment Coartem as …

News

Incyte names former Novartis president as its chief executive

January 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Incyte, Novartis, hoppenot

Biopharma firm Incyte has announced that the former president of Novartis Oncology has been named as its president and chief …

Appointment
Novartis image

Novartis faces Japan probe

January 10, 2014
Sales and Marketing Diovan, Japan, Novartis

Novartis is under pressure in Japan where authorities are looking at the way the Swiss firm promoted its blood pressure …

News
Novartis image

Novartis shuts plant in Canada cutting 300 jobs

December 16, 2013
Manufacturing and Production, Sales and Marketing Canada, Novartis, Ontario, cuts, lens, manufacturing

Novartis is shutting down its manufacturing plant in Canada which will result in 300 people losing their jobs at the …

News

€16 million fines for J&J and Novartis

December 12, 2013
Medical Communications, Sales and Marketing EU, J&J, JJ, Novartis, Sandoz, fentanyl, fines

The European Commission has slapped multi-million euro fines on Johnson & Johnson and Novartis for what it says were ‘shocking’ …

News
Lucentis image

NICE gives Lucentis more scope

November 27, 2013
Sales and Marketing Lucentis, NICE, Novartis, cnv

An undisclosed price cut from Novartis has been enough to swing NICE towards using the manufacturer’s Lucentis in a fourth …

News
novartis image

Novartis takes top honours in ISPE facility competition

November 12, 2013
Manufacturing and Production Novartis, WHO, foya, holly springs

Novartis’ cell culture facility in the US for the production of influenza vaccines has claimed the top prize in the …

News

Novartis sheds blood diagnostics for $1.7 billion

November 11, 2013
Sales and Marketing Genoptix, Novartis, blood, grifols

Novartis has announced the sale of its blood transfusion diagnostics unit to the specialist Spanish firm Grifols for $1.67 billion.Headquartered …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025